The "12th Five-Year Plan" Outline for Chemical Pharmaceuticals has been submitted for approval

Five years later, the total output value of China's pharmaceutical industry is expected to reach 3 trillion yuan.

The "12th Five-Year Plan" outline for chemical pharmaceuticals has been formulated and has now been submitted to the Ministry of Industry and Information Technology. After approval by the National Development and Reform Commission, it will be approved. On the 24th, the reporter learned from the senior leadership of the China Pharmaceutical and Pharmaceutical Industry Association that the main purpose of the “Twelfth Five-Year Plan” of the chemical and pharmaceutical industry is to “lead innovation in pharmaceutical industry development”.

By the end of the “Twelfth Five-Year Plan”, the total output value of China's pharmaceutical industry is expected to reach 3 trillion yuan.

According to Shen Xianji, deputy director of the Expert Committee of the China Chemical Pharmaceutical Industry Association, the basic principle of the "12th Five-Year Plan" for chemical pharmaceuticals is to combine the development of varieties with the transformation of the traditional pharmaceutical industry. She said that in the future, the development of the chemical and pharmaceutical industry will strongly encourage the development of biopharmaceuticals. First, it will encourage innovative drugs, secondly encourage the use of biotechnology to transform traditional medicine, and promote the upgrading of traditional medicine. At the same time, the export structure should also be adjusted.

“The current trend of China's pharmaceutical industry exports is still not optimistic.” Shen Xianji suggested that companies should expand the export market share of emerging markets, increase the domestic market share. From "OEM" (manufactured for multinational pharmaceutical companies), it gradually adjusted itself to "beating the world" with its own brand.

Pan Guangcheng, vice president of the China Chemical Pharmaceutical Industry Association, said that the structure of the chemical and pharmaceutical industry is facing a major adjustment: the company will become the main body of scientific and technological innovation; the raw material medicine production will be more environmentally friendly; the formulation production will focus on the development and use of new technologies, and more products will go international. .

According to informed sources, research and formulation of the “Twelfth Five-Year Plan” for the development of China’s health industry is nearing the end and will be introduced at the end of the year.

Ultrasonic Plastic Welder

Handheld Ultrasonic Welder,Ultrasonic Welders,Sonic Welding Plastic,Ultrasonic Welding Polypropylene

Dongguan Jinwang Ultrasonic Equipment Co.,Ltd , https://www.jwultrasonic.com